George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes Nigel does respond to messages on the portal.
Nearly a month since the last RNS. it's so frustrating when the company don't communicate.
i understand they may have very little to say but when the SP is so low you would think they would be starting to put things in motion to garner interest before it tanks more.
has anyone used the portal they advertised? Are they responding to investors?
No idea who would sell at this level. But again this is being pushed down for another rinse and repeat.
Fortunately zero is the lowest it can go. October 2023 it went to .65p if people think it’s worth selling at this price it’s their 📞. Don’t see the point myself. A director bought a junk recently. We know they can can survive to prospective clinical trials for Nanogenics in 2025. We know at least three universities are conducting research for N4p. Quite why Nigel made so obvious he was testing the water for another possible raise at this stage I don’t know or for how much. Aside from all that there is the possibility of a partnership announcement . The trouble is, is that likely to happen pre clinical trials? The report was pretty emphatic about the advantages their drug delivery technology can make to the treatments of aggressive disease.
Lowest this share has Eva been !!!
The report was commissioned by N4P so no different than a paid-for broker note in essence. I do agree though it is a solid read and hopefully will help their external comms efforts in an attempt to attract a big pharma JV
Unfortunately the markets feel pretty strange right now. Very mixed signals. ‘A rapid rise out of mild recession’ ? Certainly a lot of volatility across the board. I have been in Melbourne for last two months where the economy is extremely buoyant, although property has cooled a little. I met someone from a life science company the other evening and they were very bullish about biotech, agreeing we are on the cusp of some massive advances in medicines . Feel quite a bit more hopeful with N4p but obviously still highly risky. Gl all.
It’s not the private investor that’s going to get this noticed. There are plenty of stocks that just don’t get the investors eye, especially at a time when money is sitting on the fence. What does amaze me is how little notice the medical and drug development industry seems to be taking. The competition just in nano tech is fierce and the big money is in USA. The dots do appear to be aligning slowly, mostly in university labs it would appear at the moment. A well established drug company is where the next big leap has to come from.
It's a great report. I just don't think we promote this enough.
Highly recommend looking at the EpiVax website. Whether this is report is a commission or endorsement it is the best piece of news I have read about N4p. It almost worries me that there has been so little reaction to it. Why anyone would sell now is also quite weird. Any way new hope for holders and cancer sufferers. They must succeed.
And so we edge nearer hopefully
At last some meaningful news. An email of a report that concludes that Nuvec could help the treatment of ‘refactory cancer’, a cancer that is resistant to either the beginning of conventional treatment or becomes resistant to repeated conventional treatments. The report should help progress towards clinical trials
Https://x.com/n4pharma/status/1750092298270941486?s=46&t=8sZkNZm7bOgIzay-ij0-gA
As happens with many companies listed on AIM, they lose 90 percent or more of their value from listing , especially when they have no revenue and continually rely on placings to stay afloat. The advantage of being listed was shown when N4p was able to raise funds to buy Nanogenics recently, who not being listed could not raise the money they needed to stay afloat. This provides opportunities for listed companies to add T bargain prices. Don’t k ow why Nigel feels the need to RNS every single patent news. It’s hardly price sensitive news and they have a website and now an investor hub. Price sensitive news is when they start making money or get a partner.
Why even list on AIM at this market cap when fees are so high (relatively)
Thank you Johno77
Hi Kilsyth
It's not possible to paste an invite here. If you search for #n4p on X (Twitter) then you'll find it, I'll post it again now. Let me know if you don't see it.
Happy to keep buying at such low prices…”filling my boots”…positives from here will see a serious increase and movement potential into the “teens”…On a side note has anyone a current invite to telegram group???…thanks Kilsyth
Yes gets boring the same old people moaning about a placing every 5 mins and also after every rns.
Guess you have sold out and coming back with the negative vibes. Patent for India is such terrible news.
Yes he is building up for a placing other dilution coming .
Going to need another placing for all the RNS releases!
Good for IG to hold as long as they did. Must be all of a week! Patent granted in India ‘shows the strength of their intellectual property.’ Look forward to the day we can say thank god they did that.
IG is not an institutional shareholder. lol
Hate to see it but now we have lost the confidence of our big share holders; Selling off.